Brief: GlobeImmune authorizes eliminating majority of positions in workforce
10/06/2015 11:30
June 10 (Reuters) - GlobeImmune Inc GBIM.O : * Announces evaluation of strategic alternatives and corporate restructuring * Says in conjunction with this process, the board has authorized eliminating the majority of positions in its workforce * Says the board has authorized eliminating the majority of positions in its workforce * Says does not have a defined timeline for the strategic review process * Eliminatiion of workforce positions not expected to impact ongoing clinical trials conducted by collaborators in oncology and hepatitis b * Source text for Eikon ID:nCCN7jHrNv * Further company coverage GBIM.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on GlobeImmune
See all newsBrief: GlobeImmune announces updates
Brief: Globeimmune to delist and deregister common stock from Nasdaq Capital Market
Brief: GlobeImmune reports Q1 loss per share of $0.15
Brief: GlobeImmune hires Cantor Fitzgerald to assist in review of strategic alternatives
Brief: GlobeImmune says net income of $0.9 million for three months ended September 30, 2015